This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2005;293:2864.

Additional Financial Disclosure: Stephanie O'Malley, PhD, a coauthor of the Original Communication entitled "Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial" published in the April 6, 2005, issue of JAMA (2005;293:1617-1625) has reported an additional financial disclosure. Dr O'Malley is an inventor on a patent held by Yale University entitled "Smoking Cessation Treatments Using Naltrexone and Related Compounds."

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?